NVX-CoV2373
Facts
11 properties- Instance of
- funded product
- Official website
- www.novavaxcovidvaccine.com[17]
- Website
- www.novavaxcovidvaccine.com
- Subclass of
- COVID-19 vaccine, protein subunit vaccine, vaccine candidate[14][15][16]
- Described by source
- Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant, First-in-Human Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine, A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults, A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom[18][19][20][21]
- Funder
- Coalition for Epidemic Preparedness Innovations, United States Department of Defense, Gates Foundation, Operation Warp Speed
- Has listed ingredient
- Matrix-M
- Manufacturer
- Fujifilm Diosynth Biotechnologies, SK Bioscience, Praha Vaccines, Biofabri, Takeda Pharmaceutical Company, PolyPeptide Group, Endo International plc, Biologics Manufacturing Centre[2][3][4][5][6][7][8][9]
- On focus list of Wikimedia project
- WikiProject COVID-19
- DrugBank ID
- DB15810
- Google Knowledge Graph ID
- /g/11lll849zh
- VIOLIN ID
- 5791
- Vaccine Ontology ID
- VO_0005155
Funder 4
Developer 3
Manufacturer 2
On focus list of Wikimedia project 1
Subclass of 1
Vaccine for 1
0 sources
Summary
NVX-CoV2373 is a funded product[1].
high ≥ 0.90 · emerging ≥ 0.65 · low below — calibrated against hand-rated truth (single-source .44 · two-source .62 · production-typical .70), so a band is a measurement, not a promise. High is rare by design: it needs both a supported assertion and an evidence sentence. A confirmed or contradicted chip is a Wikidata cross-check; no chip means Wikidata has no value for that property — the ordinary case here, and it says nothing either way. A confirm-only note marks a property whose check can never disagree (Wikidata's border and capital data is not exhaustive), so silence there is a limit of the check, not of the claim.
served-tier precision 80.7% [76.2, 84.5] · rated rows currently served n=342 · entailment-gated at 0.85 · measured 2026-09-29 · re-scored every 10 min, demoted at the half-hourly fold
Show 1 low-confidence claim
Published, not hidden — scoring low is not a reason to withhold a sourced claim. A contradicted chip means Wikidata holds a different value; both are shown so you can judge.
evidence “high-teens royalties on Sanofi's Nuvaxovid global net sales restarted for 2026 and 2027.” aol.com · 2026-10-02 · read source